The critical role of mode of action studies in kinetoplastid drug discovery
- PMID: 37600222
- PMCID: PMC7614965
- DOI: 10.3389/fddsv.2023.1185679
The critical role of mode of action studies in kinetoplastid drug discovery
Abstract
Understanding the target and mode of action of compounds identified by phenotypic screening can greatly facilitate the process of drug discovery and development. Here, we outline the tools currently available for target identification against the neglected tropical diseases, human African trypanosomiasis, visceral leishmaniasis and Chagas' disease. We provide examples how these tools can be used to identify and triage undesirable mechanisms, to identify potential toxic liabilities in patients and to manage a balanced portfolio of target-based campaigns. We review the primary targets of drugs that are currently in clinical development that were initially identified via phenotypic screening, and whose modes of action affect protein turnover, RNA trans-splicing or signalling in these protozoan parasites.
Keywords: chemical proteomics; chemical pulldown; drug resistance; leishmaniasis; metabolomics; target identification; trypanosomiasis; whole genome sequencing.
Conflict of interest statement
Conflict of interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author AHF declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Figures
Similar articles
-
High-throughput screening platform for natural product-based drug discovery against 3 neglected tropical diseases: human African trypanosomiasis, leishmaniasis, and Chagas disease.J Biomol Screen. 2015 Jan;20(1):82-91. doi: 10.1177/1087057114555846. Epub 2014 Oct 20. J Biomol Screen. 2015. PMID: 25332350
-
Experimental Strategies to Explore Drug Action and Resistance in Kinetoplastid Parasites.Microorganisms. 2020 Jun 24;8(6):950. doi: 10.3390/microorganisms8060950. Microorganisms. 2020. PMID: 32599761 Free PMC article. Review.
-
An Overview on Target-Based Drug Design against Kinetoplastid Protozoan Infections: Human African Trypanosomiasis, Chagas Disease and Leishmaniases.Molecules. 2021 Jul 30;26(15):4629. doi: 10.3390/molecules26154629. Molecules. 2021. PMID: 34361781 Free PMC article. Review.
-
Screening a Natural Product-Based Library against Kinetoplastid Parasites.Molecules. 2017 Oct 12;22(10):1715. doi: 10.3390/molecules22101715. Molecules. 2017. PMID: 29023425 Free PMC article.
-
Finding new hits in neglected disease projects: target or phenotypic based screening?Curr Top Med Chem. 2011;11(10):1284-91. doi: 10.2174/156802611795429176. Curr Top Med Chem. 2011. PMID: 21401505
Cited by
-
The Potential Use of Peptides in the Fight against Chagas Disease and Leishmaniasis.Pharmaceutics. 2024 Feb 4;16(2):227. doi: 10.3390/pharmaceutics16020227. Pharmaceutics. 2024. PMID: 38399281 Free PMC article. Review.
-
RES-Seq-a barcoded library of drug-resistant Leishmania donovani allowing rapid assessment of cross-resistance and relative fitness.mBio. 2023 Dec 19;14(6):e0180323. doi: 10.1128/mbio.01803-23. Epub 2023 Nov 6. mBio. 2023. PMID: 37929970 Free PMC article.
References
Grants and funding
LinkOut - more resources
Full Text Sources